Understanding Treatment Refusal Among Adults Presenting for HIV-Testing in Soweto, South Africa: A Qualitative Study

AIDS and Behavior

Volumn 19, Issue 4, 2015, Pages 704-714

  Katz, Ingrid T ^a,b,c   Dietrich, Janan ^d   Tshabalala, Gugu ^d   Essien, Thandekile ^d   Rough, Kathryn ^a,e   Wright, Alexi A ^b,f   Bangsberg, David R ^b,c   Gray, Glenda E ^d   Ware, Norma C ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d Perinatal HIV Research Unit   (South Africa)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Antiretroviral refusal; ART initiation; Engagement in care; Linkage to care; South Africa; Treatment refusal

Indexed keywords

ADULT; ASYMPTOMATIC INFECTION; ATTITUDE TO HEALTH; FEMALE; HIV INFECTIONS; HUMAN; INTERPERSONAL COMMUNICATION; MALE; PSYCHOLOGY; QUALITATIVE RESEARCH; SOCIAL ISOLATION; SOCIAL STIGMA; SOCIAL SUPPORT; SOUTH AFRICA; TREATMENT REFUSAL;

ADULT; ASYMPTOMATIC INFECTIONS; ATTITUDE TO HEALTH; DISCLOSURE; FEMALE; HIV INFECTIONS; HUMANS; MALE; QUALITATIVE RESEARCH; SOCIAL ISOLATION; SOCIAL STIGMA; SOCIAL SUPPORT; SOUTH AFRICA; TREATMENT REFUSAL;

EID: 84938150283     PISSN: 10907165     EISSN: 15733254     Source Type: Journal    
DOI: 10.1007/s10461-014-0920-y     Document Type: Article

References (53)

1. The gap report [Internet]. UN Joint Programme on HIV/AIDS (UNAIDS). http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2014/UNAIDS_Gap_report_en.pdf (2014). Accessed 7 Oct 2014.
2. Katz IT, Bassett IV, Wright AA. PEPFAR in transition—implications for HIV care in South Africa. N Engl J Med. 2013;369:1385–7.
3. Department of State: The Office of Electronic Information B of PA. Treatment: direct FY2013 antiretroviral treatment results [Internet]. http://www.pepfar.gov/press/222831.htm (2014). Accessed 7 Oct 2014.
4. United States President’s Emergency Plan for AIDS Relief: South Africa operational plan report FY 2012 [Internet]. http://www.pepfar.gov/documents/organization/212156.pdf (2013). Accessed 7 Oct 2014.
5. Shisana O, Rehle T, Simbayi L, Zuma K, Jooste S, Zungu N, et al. South African National HIV Prevalence, Incidence and Behaviour Survey [Internet]. Human Sciences Research Council Press; 2014. http://www.hsrc.ac.za/uploads/pageContent/4565/SABSSM%20IV%20LEO%20final.pdf. Accessed 7 Oct 2014.
6. Kranzer K, Zeinecker J, Ginsberg P, Orrell C, Kalawe NN, Lawn SD, et al. Linkage to HIV care and antiretroviral therapy in Cape Town, South Africa. PLoS ONE. 2010;5(11):e13801.
7. Joint United Nations Programme on HIV/AIDS. Global report UNAIDS report on the global AIDS epidemic: 2012 [Internet]. Geneva: UNAIDS; 2012. http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2012/gr2012/20121120_UNAIDS_Global_Report_2012_en.pdf. Accessed 7 Oct 2014.
8. Patten GE, Cox V, Stinson K, Boulle AM, Wilkinson LS. Advanced HIV disease at antiretroviral therapy (ART) initiation despite implementation of expanded ART eligibility guidelines during 2007–2012 in Khayelitsha, South Africa. Clin Infect Dis Off Publ Infect Dis Soc Am. 2014;59:456–7.
9. Smith LR, Amico KR, Shuper PA, Christie S, Fisher WA, Cornman DH, et al. Information, motivation, and behavioral skills for early pre-ART engagement in HIV care among patients entering clinical care in KwaZulu-Natal, South Africa. AIDS Care. 2013;25:1485–90.
10. Bassett IV, Regan S, Chetty S, Giddy J, Uhler LM, Holst H, et al. Who starts antiretroviral therapy in Durban, South Africa?… not everyone who should. AIDS Lond Engl. 2010;24(Suppl 1):S37–44.
11. Curran K, Ngure K, Shell-Duncan B, Vusha S, Mugo NR, Heffron R, et al. “If I am given antiretrovirals I will think I am nearing the grave”: Kenyan HIV serodiscordant couples’ attitudes regarding early initiation of antiretroviral therapy. AIDS Lond Engl. 2014;28:227–33.
12. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493–505.
13. Anglemyer A, Rutherford GW, Horvath T, Baggaley RC, Egger M, Siegfried N. Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples. Cochrane Database Syst Rev. 2013;4:CD009153.
14. Tanser F, Bärnighausen T, Grapsa E, Zaidi J, Newell M-L. High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science. 2013;339:966–71.
15. Cloete C, Regan S, Giddy J, Govender T, Erlwanger A, Gaynes MR, et al. The linkage outcomes of a large-scale, rapid transfer of HIV-infected patients from hospital-based to community-based clinics in South Africa. Open Forum Infect Dis. 2014;1:ofu058.
16. Katz IT, Essien T, Marinda ET, Gray GE, Bangsberg DR, Martinson NA, et al. Antiretroviral refusal among newly diagnosed HIV-infected adults in Soweto, South Africa. AIDS Lond Engl. 2011;25:2177–81.
17. Heffron R, Ngure K, Mugo N, Celum C, Kurth A, Curran K, et al. Willingness of Kenyan HIV-1 serodiscordant couples to use antiretroviral-based HIV-1 prevention strategies. J Acquir Immune Defic Syndr. 2012;61:116–9.
18. Mujugira A, Celum C, Thomas KK, Farquhar C, Mugo N, Katabira E, et al. Delay of antiretroviral therapy initiation is common in East African HIV-infected individuals in serodiscordant partnerships. J Acquir Immune Defic Syndr. 2014;66:436–42.
19. Nachega JB, Uthman OA, del Rio C, Mugavero MJ, Rees H, Mills EJ. Addressing the Achilles’ heel in the HIV care continuum for the success of a test-and-treat strategy to achieve an AIDS-free generation. Clin Infect Dis. 2014;59:S21–7.
20. Geng EH, Bwana MB, Muyindike W, Glidden DV, Bangsberg DR, Neilands TB, et al. Failure to initiate antiretroviral therapy, loss to follow-up and mortality among HIV-infected patients during the pre-ART period in Uganda. J Acquir Immune Defic Syndr. 2013;63:e64–71.
21. Stinson K, Myer L. Barriers to initiating antiretroviral therapy during pregnancy: a qualitative study of women attending services in Cape Town, South Africa. Afr J AIDS Res. 2012;11:65–73.
22. Anon. Chris Hani Baragwanath Hospital website [Internet]. http://www.chrishanibaragwanathhospital.co.za. Accessed 7 Oct 2014.
23. Meintjes G, Maartens G, Boulle A, Conradie F, Goemaere E. South African treatment guidelines. S Afr J HIV Med. 2012;13:114–33.
24. Creswell JW. Qualitative inquiry and research design: choosing among five traditions. 1st ed. Thousand Oaks: SAGE Publications, Inc.; 1997.
25. Rosen S, Fox MP. Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med. 2011;8:e1001056.
26. Strauss AC, Corbin JM. Basics of qualitative research: second edition: techniques and procedures for developing grounded theory. 2nd ed. Thousand Oaks: SAGE Publications, Inc.; 1998.
27. Tversky A, Kahneman D. Judgment under uncertainty: heuristics and biases. Science. 1974;185:1124–31.
28. Finucane ML, Alhakami A, Slovic P, Johnson SM. The affect heuristic in judgments of risks and benefits. J Behav Decis Mak. 2000;13:1–17.
29. Kahn TR, Desmond M, Rao D, Marx GE, Guthrie BL, Bosire R, et al. Delayed initiation of antiretroviral therapy among HIV-discordant couples in Kenya. AIDS Care. 2013;25:265–72.
30. Unge C, Johansson A, Zachariah R, Some D, Van Engelgem I, Ekstrom AM. Reasons for unsatisfactory acceptance of antiretroviral treatment in the urban Kibera slum, Kenya. AIDS Care. 2008;20:146–9.
31. Tsai AC, Bangsberg DR. The importance of social ties in sustaining medication adherence in resource-limited settings. J Gen Intern Med. 2011;26:1391–3.
32. Bangsberg DR, Deeks SG. Spending more to save more: interventions to promote adherence. Ann Intern Med. 2010;152:54–6; W-13.
33. Ware NC, Idoko J, Kaaya S, Biraro IA, Wyatt MA, Agbaji O, et al. Explaining adherence success in sub-Saharan Africa: an ethnographic study. PLoS Med. 2009;6:e1000011.
34. Weiser SD, Tuller DM, Frongillo EA, Senkungu J, Mukiibi N, Bangsberg DR. Food insecurity as a barrier to sustained antiretroviral therapy adherence in Uganda. PLoS ONE. 2010;5:e10340.
35. Tuller DM, Bangsberg DR, Senkungu J, Ware NC, Emenyonu N, Weiser SD. Transportation costs impede sustained adherence and access to HAART in a clinic population in southwestern Uganda: a qualitative study. AIDS Behav. 2010;14:778–84.
36. Tsai AC, Bangsberg DR, Emenyonu N, Senkungu JK, Martin JN, Weiser SD. The social context of food insecurity among persons living with HIV/AIDS in rural Uganda. Soc Sci Med. 1982;2011(73):1717–24.
37. Ware NC, Wyatt MA, Tugenberg T. Social relationships, stigma and adherence to antiretroviral therapy for HIV/AIDS. AIDS Care. 2006;18:904–10.
38. Samuels FA, Rutenberg N. “Health regains but livelihoods lag”: findings from a study with people on ART in Zambia and Kenya. AIDS Care. 2011;23:748–54.
39. Izugbara CO, Wekesa E. Beliefs and practices about antiretroviral medication: a study of poor urban Kenyans living with HIV/AIDS. Sociol Health Illn. 2011;33:869–83.
40. Katz IT, Ryu AE, Onuegbu AG, Psaros C, Weiser SD, Bangsberg DR, et al. Impact of HIV-related stigma on treatment adherence: systematic review and meta-synthesis. J Int AIDS Soc. 2013;16 [Internet]. http://www.jiasociety.org/index.php/jias/article/view/18640. Accessed 7 Oct 2014.
41. MacPherson P, MacPherson EE, Mwale D, Squire SB, Makombe SD, Corbett EL, et al. Barriers and facilitators to linkage to ART in primary care: a qualitative study of patients and providers in Blantyre, Malawi. J Int AIDS Soc. 2012;15 [Internet]. http://www-ncbi-nlm-nih-gov.ezproxy.bu.edu/pmc/articles/PMC3535694/. Accessed 7 Oct 2014.
42. Kalichman SC, Simbayi LC, Jooste S, Toefy Y, Cain D, Cherry C, et al. Development of a brief scale to measure AIDS-related stigma in South Africa. AIDS Behav. 2005;9:135–43.
43. Wolfe WRW, Weiser SD, Bangsberg DR, Thior I, Makhema JM, Dickinson DB, Mompati KF, Marlink RG. Effects of HIV-related stigma among an early sample of patients receiving antiretroviral therapy in Botswana. AIDS Care. 2006;18:931–3.
44. Roura M, Urassa M, Busza J, Mbata D, Wringe A, Zaba B. Scaling up stigma? The effects of antiretroviral roll-out on stigma and HIV testing. Early evidence from rural Tanzania. Sex Transm Infect. 2009;85:308–12.
45. Mansergh G, Marks G, Simoni JM. Self-disclosure of HIV infection among men who vary in time since seropositive diagnosis and symptomatic status. AIDS Lond Engl. 1995;9:639–44.
46. Hays RB, McKusick L, Pollack L, Hilliard R, Hoff C, Coates TJ. Disclosing HIV seropositivity to significant others. AIDS Lond Engl. 1993;7:425–31.
47. Patel R, Ratner J, Gore-Felton C, Kadzirange G, Woelk G, Katzenstein D. HIV disclosure patterns, predictors, and psychosocial correlates among HIV positive women in Zimbabwe. AIDS Care. 2012;24:358–68.
48. Alonzo AA, Reynolds NR. Stigma, HIV and AIDS: an exploration and elaboration of a stigma trajectory. Soc Sci Med. 1982;1995(41):303–15.
49. Nam SL, Fielding K, Avalos A, Dickinson D, Gaolathe T, Geissler PW. The relationship of acceptance or denial of HIV-status to antiretroviral adherence among adult HIV patients in urban Botswana. Soc Sci Med. 1982;2008(67):301–10.
50. Green HD, Atuyambe L, Ssali S, Ryan GW, Wagner GJ. Social networks of PLHA in Uganda: implications for mobilizing PLHA as agents for prevention. AIDS Behav. 2011;15:992–1002.
51. Guthrie BL, Choi RY, Liu AY, Mackelprang RD, Rositch AF, Bosire R, et al. Barriers to antiretroviral initiation in HIV-1-discordant couples. J Acquir Immune Defic Syndr. 1999;2011(58):e87–93.
52. Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373:48–57.
53. Hayes R, Ayles H, Beyers N, Sabapathy K, Floyd S, Shanaube K, et al. HPTN 071 (PopART): rationale and design of a cluster-randomised trial of the population impact of an HIV combination prevention intervention including universal testing and treatment—a study protocol for a cluster randomised trial. Trials. 2014;15:57.